BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kozłowska E, Brzezińska-Błaszczyk E, Agier J, Wysokiński A, Żelechowska P. Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia. J Psychiatr Res 2021;138:380-7. [PMID: 33957300 DOI: 10.1016/j.jpsychires.2021.04.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Park JH. Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder. IJMS 2022;23:13054. [DOI: 10.3390/ijms232113054] [Reference Citation Analysis]
2 Chen S, Gou M, Chen W, Xiu M, Fan H, Tan Y, Tian L. Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls. Front Psychiatry 2022;13:1024299. [DOI: 10.3389/fpsyt.2022.1024299] [Reference Citation Analysis]
3 Góralczyk-bińkowska A, Szmajda-krygier D, Kozłowska E. The Microbiota–Gut–Brain Axis in Psychiatric Disorders. IJMS 2022;23:11245. [DOI: 10.3390/ijms231911245] [Reference Citation Analysis]
4 Serna-Rodríguez MF, Bernal-Vega S, de la Barquera JAO, Camacho-Morales A, Pérez-Maya AA. The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation. J Neuroimmunol 2022;371:577951. [PMID: 35994946 DOI: 10.1016/j.jneuroim.2022.577951] [Reference Citation Analysis]
5 Cai H, Zeng C, Zhang X, Liu Y, Wu R, Guo W, Wang J, Wu H, Tang H, Ge X, Yu Y, Zhang S, Cao T, Li N, Liang X, Yang P, Zhang B. Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study. Psychiatry Res 2022;316:114762. [PMID: 35940088 DOI: 10.1016/j.psychres.2022.114762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ma H, Cheng N, Zhang C. Schizophrenia and Alarmins. Medicina (Kaunas) 2022;58:694. [PMID: 35743957 DOI: 10.3390/medicina58060694] [Reference Citation Analysis]
7 Vastrad B, Vastrad C. Identification of Key Genes and Biological Pathways in Bipolar Disorder by Bioinformatics and Next Generation Sequencing Data Analysis.. [DOI: 10.1101/2022.04.29.489994] [Reference Citation Analysis]
8 Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, Patschan D. Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification? J Circ Biomark 2021;10:20-5. [PMID: 34858526 DOI: 10.33393/jcb.2021.2327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]